TCT-30 PREMIUM Trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER® PFO Occluder as a treatment for migraine with or without aura

Abstract

Open access

Peer reviewed

Jonathan Tobis, Andrew Charles, Stephen D. Silberstein, Sherman Sorensen, Brij Maini, Phillip A. Horwitz and John c Gurley

Journal of the American College of Cardiology, Vol.66(15), pp.B13-B13

10/13/2015

DOI: 10.1016/j.jacc.2015.08.076

Files and links (1)

url

https://doi.org/10.1016/j.jacc.2015.08.076View

Published (Version of record) Open Access

Title: Subtitle: TCT-30 PREMIUM Trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER® PFO Occluder as a treatment for migraine with or without aura
Creators: Jonathan Tobis - University of California, Los Angeles
Andrew Charles - University of California, Los Angeles
Stephen D. Silberstein - Thomas Jefferson University
Sherman Sorensen - Great Basin Cardiovascular, Murray, Utah
Brij Maini - PinnacleHealth Cardiovascular Institute, Wormleysburg, Pennsylvania.
Phillip A. Horwitz - Roy J. and Lucille A. Carver College of Medicine
John c Gurley - University of Kentucky
Resource Type: Abstract
Publication Details: Journal of the American College of Cardiology, Vol.66(15), pp.B13-B13
DOI: 10.1016/j.jacc.2015.08.076
ISSN: 0735-1097
eISSN: 1558-3597
Publisher: Elsevier Inc
Language: English
Date published: 10/13/2015
Academic Unit: Cardiovascular Medicine; Internal Medicine
Record Identifier: 9984362354702771

5 Record Views